Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Palisade Bio
Biotech
Prominent vaccine critic ousted from HHS—Chutes & Ladders
Prominent vaccine critic ousted from HHS. Organon CEO steps down in sales snafu. Evaxion snatches up seasoned CEO.
Darren Incorvaia
,
Zoey Becker
Oct 31, 2025 8:30am
Palisade's ulcerative colitis drug prevents symptoms in mice
May 23, 2024 4:30am
Palisade's stock collapses as sole asset flunks phase 2 GI trial
Aug 9, 2023 10:35am
Former Roche pharma head to be new Bayer CEO—Chutes & Ladders
Feb 10, 2023 9:30am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
With cash evaporating quickly, Palisade Bio cuts 20% of staff
Sep 15, 2022 4:50pm
